Sophia Randolph is CHIEF MEDICAL OFFICER at ALX ONCOLOGY HOLDINGS INC (ALXO). They have made 14 open-market trades across 1 company since 2021, most recently 2024-08-14.
CIK 0001817127
Unrated. We grade insiders only on stock they chose to buy on the open market. Grants, option exercises and vesting say nothing about timing, so they don't count — which is why someone can file often and still have no grade. It isn't a bad sign: unrated buys beat every graded tier below A.
0 open-market purchases, against 14 sales. Too few scored purchases to measure a record yet.
| Ticker | Shares | Value |
|---|---|---|
| ALXO | 325,711 | $443K |
Shares reported on the most recent Form 4, priced at the 2024-08-16 close.
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| ALXO | SELL | 2024-08-14 | 2024-08-16 | $2.58 | $4K | -6.8% | -13.1% | -47.0% |
| ALXO | SELL | 2024-07-01 | 2024-07-03 | $5.82 | $19K | +47.8% | -48.0% | -66.2% |
| ALXO | SELL · 10b5-1 | 2024-05-13 | 2024-05-15 | $15.89 | $353K | -16.2% | -46.3% | -82.4% |
| ALXO | SELL | 2023-12-29 | 2024-01-03 | $15.04 | $47K | +2.8% | +8.2% | -21.1% |
| ALXO | SELL | 2023-06-30 | 2023-07-05 | $7.34 | $12K | +5.1% | -15.0% | +14.8% |
| ALXO | SELL | 2022-12-29 | 2023-01-03 | $11.07 | $18K | -11.8% | -18.7% | -59.4% |
| ALXO | SELL | 2021-11-22 | 2021-11-23 | $36.77 | $1.1M | -10.8% | -34.3% | -56.0% |
| ALXO | SELL | 2021-10-11 | 2021-10-12 | $60.98 | $901K | -9.1% | -26.5% | -66.8% |
| ALXO | SELL | 2021-09-10 | 2021-09-13 | $77.74 | $1.1M | +0.7% | -24.6% | -69.9% |
| ALXO | SELL | 2021-08-10 | 2021-08-11 | $64.63 | $950K | +11.1% | +18.9% | -37.4% |
| ALXO | SELL | 2021-07-12 | 2021-07-14 | $54.88 | $794K | +8.8% | +25.7% | +12.3% |
| ALXO | SELL | 2021-06-10 | 2021-06-14 | $60.88 | $899K | -8.4% | -11.9% | +29.8% |
| ALXO | SELL | 2021-05-10 | 2021-05-11 | $62.08 | $793K | -8.7% | +2.2% | +9.3% |
| ALXO | SELL | 2021-04-12 | 2021-04-13 | $59.32 | $785K | +9.3% | -8.6% | -4.8% |
| ALXO | SELL | 2021-03-10 | 2021-03-12 | $74.33 | $1.1M | -19.3% | -25.6% | -21.7% |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.